Pharming Group N.V. / Fundamentals
Income statement
- Net revenue
€293.32M - Cost of goods sold
€31.35M - Gross profit
€261.97M - SG&A expenses
€98.29M - R&D expenses
€75.79M - EBITDA
€24.63M - D&A
€13.57M - EBIT
€12.61M - Interest expenses
€8.06M - EBT
€3.00M - Tax expenses
€10.35M - Net income
-€7.07M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€55.21K - Changes in working capital
€250.15K - Operating cash flow
€26.78M - Capex
€791.86K - Other investing cash flow
-€93.66K - Net investing cash flow
€18.29M - Total cash dividends paid
€0.00 - Issuance of common stock
€23.08K - Debt repayment
-€3.87M - Other financing cash flow
-€7.44M - Net financing cash flow
-€11.31M - Foreign exchange effects
€5.01M - Net change in cash
€38.77M - Cash at end of period
€79.44M - Free cash flow
€27.57M
Balance sheet
- Cash and cash equivalents
€79.44M - Cash and short-term investments
€108.69M - Total receivables
€46.00M - Inventory
€54.96M - Other current assets
€2.35M - Total current assets
€212.00M - Property, plant & equipment
€21.19M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€5.78M - Other non-current assets
€1.83M - Total non-current assets
€172.93M - Total assets
€384.94M - Accounts payable
€67.61M - Short-term debt
€8.25M - Other current liabilities
€0.00 - Total current liabilities
€75.86M - Long-term debt
€102.45M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€102.45M - Total liabilities
€178.30M - Common stock
€6.75M - Retained earnings
-€246.73M - Other equity
€22.35M - Total equity
€206.63M - Total liabilities and shareholders' equity
€384.94M
Company information
- Market capitalization
€638.51M - Employees
404 - Enterprise Value
€846.17M
Company ratios
- Gross margin
-
89.3% Much better than peer group: -470.2% - EBITDA margin
-
8.4% Much better than peer group: -822.6% - EBIT margin
-
4.3% Much better than peer group: -120.7% - EBT margin
-
1.0% Much worse than peer group: 5,317.0% - Net margin
-
-2.4% Much worse than peer group: 3,845.6% - ROE
-
-3.4% Much better than peer group: -267.4% - ROA
-
-1.8% Much better than peer group: -121.5% - Asset turnover
-
76.2% Much better than peer group: 23.8% - FCF margin
-
8.9% Much worse than peer group: 2,979.9% - FCF yield
4.1% - Efficiency ratio
91.6% - Net sales per employee
-
€726.05K - Net income per employee
-
-€17.51K